<?xml version="1.0" encoding="UTF-8"?>
<p id="par0165">When preparing for possible future epidemics, it is better to be safe than sorry; for example, the US Government has a stockpile of tecovirimat, a drug used to treat smallpox, in the event of an act of bioterrorism 
 <xref rid="bib0225" ref-type="bibr">[45]</xref>. This drug was developed solely to prevent a future outbreak; smallpox was eradicated decades ago through global vaccination efforts. Similar prescient efforts are underway to prevent the next pandemic, such as the Rapidly Emerging Antiviral Drug Discovery Initiative (READDI). This initiative is aiming to create and stockpile a novel broad-spectrum antiviral drug in preparation for the next pandemic 
 <xref rid="bib0230" ref-type="bibr">[46]</xref>. The history of HIV and AIDS shows clearly that steady interest and robust investment in the study of the disease have yielded the desired fruits. Although the speed of response to COVID-19 by both the research community and the public is unprecedented, the world needs to pay more attention to infectious diseases before they have the opportunity to cause lasting economic, social, and physical damage to people around the globe 
 <xref rid="bib0235" ref-type="bibr">[47]</xref>.
</p>
